韩冰

作者: 时间:2021-07-02 点击数:

姓名

Bing Han

韩冰

职称

Professor

教授

办公地点

Room 204

204室

办公电话

0431-85619716

邮箱

hanb@jlu.edu.cn

教育背景

2004-2006 MSc, Pharmacy, School of Pharmacy, Jilin University

2004-2006 吉林大学,药学,硕士

2006-2010 PhD, Pharmacy, School of Pharmacy, Jilin University

2006-2010 吉林大学,药学,博士

工作经历

2020- Professor & Doctoral Supervisor, School of Pharmaceutical Sciences, Jilin University

2020- 吉林大学,3044am永利集团官网vip,教授

2015-2020 Associate Professor & Master Supervisor,School of Pharmaceutical Sciences, Jilin University

2015-2020 吉林大学,3044am永利集团官网vip,副教授

主讲课程

Bioharmaceutics

生物药物制剂学

Professional Foreign Language

专业外语

研究领域

Administration of Drugs in Ophthalmology and Otorhinolaryngology,Nanoformulation

眼鼻耳喉药物递送,纳米药物剂型

科研成果

Publication:

1. Bing Han, Yue Yang, Jinglin Chen, Huan Tang, Yuxin Sun, Zheng Zhang, Zeng Wang, Yan Li, Yao Li, Xue Luan, Qianwen Li, Zhihui Ren, Xiaowei Zhou, Dengli Cong, Zhiyi Liu, Qin Meng, Fei Sun, and Jin Pei*, Preparation, Characterization, and Pharmacokinetic Study of a Novel Long-Acting Targeted Paclitaxel Liposome with Antitumor Activity. Int J Nanomedicine. 2020 Jan 24;15:553-571.

2. Bixi Sun, Shuwen Liu, Rubin Hao, Xinyue Dong, Lanbo Fu, Bing Han*, RGD-PEG-PLA Delivers MiR-133 to Infarct Lesions of Acute Myocardial Infarction Model Rats for Cardiac Protection, Pharmaceutics. 2020 Jun 21;12(6):575.

3. Yu Su, Bixi Sun, Xiaoshu Gao, Shuwen Liu, Rubin Hao, Bing Han*, Chitosan Hydrogel Doped with PEG-PLA Nanoparticles for the Local Delivery of miRNA-146a to Treat Allergic Rhinitis, Pharmaceutics. 2020 Sep 23;12(10):907.

4. Siqi Pan, Yu Su, Bixi Sun, Rubin Hao, Xiaoshu Gao, Bing Han*, Knockout of CD147 inhibits the proliferation, invasion, and drug resistance of human oral cancer CAL27 cells in Vitro and in Vivo, Int J Biol Macromol. 2021 Mar 23;181:378-389.

5. Bing Han, Huan Tang., Qiming Liang, Ming Zhu, Yizhuo Xie, Jinglin Chen, Qianwen Li, Juan Jia, Yan Li, Zhihui Ren, Dengli Cong, Xiaofeng Yu, Dayun Sui, and Jin Pei*, Preparation of long-acting microspheres loaded with octreotide for the treatment of portal hypertensive. Drug delivery, 2021 Dec;28(1):719-732.

版权所有:中国·永利集团-www.3044am.com|VIP官网登录